A lower-cost insulin manufacturer has taken the next step toward establishing a location in West Virginia. UNDBIO, a South Korean company, has secured a lease with West Virginia University to build an ...

--(BUSINESS WIRE)--Optum Rx, a pharmacy services company, today announced additional actions to make insulin more affordable, moving several rapid-, short- and long-acting insulins to tier one, which ...

TULSA, Okla. — One of the largest drug manufacturers of insulin is drastically decreasing the out-of-pocket costs for the medicine. And while it may be a step in the right direction, many say more ...

Differentiating stem cells into high-quality insulin-producing cells on a large scale for therapeutic manufacturing is a common bottleneck in translational research. In a study published in Stem Cell ...

SACRAMENTO — California is diving into the prescription drug business, attempting to achieve what no other state has done: produce its own brand of generic insulin and sell it at below-market prices ...

Congress failed to pass a proposal that would have capped out-of-pocket insulin costs at $35 a month for people not covered by Medicare. More than 34 million Americans have diabetes, and it’s ...

Medicare beneficiaries will pay no more than $35 a month for insulin in 2023, while ongoing work will be needed to ensure that everyone in the United States with diabetes who needs insulin can afford ...

LEHI, Utah--(BUSINESS WIRE)--Civica Inc. (Civica, Civica Rx) today announced it will manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative as part of its insulin ...

Lest you think the baby formula shortage occurred overnight or is an isolated problem, think again. It can and will be solved with fewer regulations, a worldwide market, a Trumpian style ...